This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

October 25-28, 2021
Delivered in a 100% Digital Format

Wei Zhang, Ph.D.
Associate Director at Biogen


Dr. Zhang is currently working in the Bioassay Group of the Analytical Development Department of Biogen and is responsible for development and qualification of binding and cell-based potency assays as well as impurity assays for process development, product release and stability testing of Biogen’s therapeutic protein and gene therapy products. His group also manages inventory and production of critical reagents for bioassays. Before he joined Biogen, he had worked at Genzyme and Phylos on assay development for various projects, including gene and cell therapies and protein binder screening. He received his B.S. from Peking University and Ph.D. from Cornell University. He did his post-doctoral work at the Brigham and Women’s Hospital of Harvard Medical School.

Wei Zhang, Ph.D.'s Network

Agenda Sessions

  • Conducting Biological Assays for Cell & Gene Therapies

  • Featured Presentation: Bioassay Strategies for AAV Gene Therapy Products

  • Live Q & A with Rajeev Boregowda, Wei Zhang, and Nathan Oien